लोड हो रहा है...
Can we avoid dose escalation for intermediate-risk prostate cancer in the setting of short-course neoadjuvant androgen deprivation?
BACKGROUND: Both dose-escalated external beam radiotherapy (DE-EBRT) and androgen deprivation therapy (ADT) improve the outcomes in patients with intermediate-risk prostate cancer. Despite this, there are only few reports evaluating DE-EBRT for patients with intermediate-risk prostate cancer receivi...
में बचाया:
में प्रकाशित: | Onco Targets Ther |
---|---|
मुख्य लेखकों: | , , |
स्वरूप: | Artigo |
भाषा: | Inglês |
प्रकाशित: |
Dove Medical Press
2016
|
विषय: | |
ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4806761/ https://ncbi.nlm.nih.gov/pubmed/27073327 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S102327 |
टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|